HealthEquity Reports First Quarter Ended April 30, 2021 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Dow tick higher as investors weigh Mideast negotiations
- Oil falls 4% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
- Sanuwave cuts Q2 2026 revenue guidance amid Ultramist sales pressure
HealthEquity (HQY) Tops Q1 EPS by 6c, Revenues Beat; Offers FY22 EPS/Guidance Above Consensus
June 7, 2021 4:06 PM EDTHealthEquity (NASDAQ: HQY) reported Q1 EPS of $0.38, $0.06 better than the analyst estimate of $0.32. Revenue for the quarter came in at $184.2 million versus the consensus estimate of $180.84 million.
Highlights of the first quarter include:
Revenue of $184.2 million, a decrease of 3% compared to $190.0 million in Q1 FY21.Net loss of $2.6 million, compared to net income of $1.8 million in Q1 FY21, with non-GAAP net income of $31.0 million, compared to $30.8 million in Q1 FY21.Net loss per diluted share of $0.03, compared to net income per diluted share of... More